SPISANI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 7.056
EU - Europa 1.684
AS - Asia 1.219
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 1
OC - Oceania 1
Totale 9.973
Nazione #
US - Stati Uniti d'America 7.056
CN - Cina 758
UA - Ucraina 570
DE - Germania 334
TR - Turchia 305
GB - Regno Unito 219
IT - Italia 203
FI - Finlandia 133
SE - Svezia 132
SG - Singapore 88
VN - Vietnam 33
FR - Francia 31
BE - Belgio 16
PL - Polonia 13
RU - Federazione Russa 11
IR - Iran 9
NL - Olanda 9
IN - India 8
CZ - Repubblica Ceca 7
HK - Hong Kong 7
CL - Cile 5
EU - Europa 4
ID - Indonesia 3
BR - Brasile 2
GR - Grecia 2
JP - Giappone 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
BG - Bulgaria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
IE - Irlanda 1
IL - Israele 1
IQ - Iraq 1
PH - Filippine 1
PS - Palestinian Territory 1
TH - Thailandia 1
Totale 9.973
Città #
Woodbridge 962
Fairfield 941
Houston 653
Jacksonville 621
Chandler 536
Ann Arbor 485
Ashburn 437
Seattle 355
Wilmington 352
Cambridge 285
Izmir 196
Nanjing 184
Beijing 169
Princeton 125
New York 94
San Diego 94
Boardman 88
Milan 77
Shanghai 66
Bremen 61
Ferrara 56
Nanchang 53
Shenyang 48
Singapore 44
Hebei 41
Addison 37
Tianjin 34
Changsha 33
Dong Ket 33
San Mateo 30
Jinan 27
Auburn Hills 22
Mountain View 22
Jiaxing 20
Helsinki 18
Verona 17
London 16
Philadelphia 15
Kunming 14
Brussels 13
Dearborn 13
Tappahannock 13
Augusta 12
Norwalk 12
Redwood City 12
Warsaw 12
Los Angeles 11
Ningbo 10
Zhengzhou 10
Taizhou 9
Falls Church 8
Indiana 8
Leawood 8
Ardabil 7
Hong Kong 7
Fuzhou 6
Lanzhou 6
Orange 6
Brno 5
Guangzhou 5
Haikou 5
Kilburn 5
Monmouth Junction 5
Bologna 4
Des Moines 4
Hangzhou 4
Redmond 4
Acton 3
Amsterdam 3
Ferrara di Monte Baldo 3
Gent 3
Jakarta 3
Qingdao 3
Rho 3
Taiyuan 3
Brindisi 2
Castenaso 2
Chicago 2
Hounslow 2
Iesi 2
Irving 2
New Bedfont 2
Olomouc 2
Paris 2
Parma 2
Phoenix 2
Walnut 2
Wandsworth 2
Washington 2
Yellow Springs 2
Americana 1
Amiens 1
Andover 1
Bangkok 1
Changchun 1
Chiswick 1
Clearwater 1
Dallas 1
Dublin 1
Düsseldorf 1
Totale 7.649
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 240
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 190
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 164
A CYCLIC PEPTIDE T ANALOGUE WITH HIGH CHEMOTACTIC ACTIVITY 149
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 138
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 132
Modulation of neutrophil functions by activated platelet release factors 126
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis 122
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 119
6-(hydroxyphenyl)imidazo[2,1-b]thiazoles as potential antiinflammatory agents: Effects on human neutrophil functions 115
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 115
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 113
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 112
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 110
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 110
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
Ring-opened analogs of indomethacin affecting human neutrophil functions 109
Dual mechanism in induction of human neutrophil cytotoxicity: activation of protein kinase C and elevation in intracellular calcium 108
Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue 108
Conformational Aspects of Human Formyl-peptide Receptor Agonists 108
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 108
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 107
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 105
Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe 105
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 104
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH. 104
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 104
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 103
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For‐Hse(Me)‐Leu‐Phe‐OMe 102
Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T 101
Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues 99
A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs. 98
Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2 98
Conformational aspects of human formylpeptide receptor antagonists 98
SYNTHESIS AND PROPERTIES OF CHEMOTACTIC PEPTIDE ANALOGS 97
Synthesis and bioactivity of chemotactic tetrapeptides: fMLF-OMe analogues incorporating spacer aminoacids at the lateral positions. 96
Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs. 96
null 96
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 95
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 95
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 94
Conformation-activity relationship of peptide t and new pseudocyclic hexapeptide analogs 94
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity 94
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 94
The importance of the methionine configuration in for-Met-Leu-Phe-OMe biological activities. 93
Exploring the interest of 1,2-Dithiolane ring system in peptide chemistry. Synthesis of a chemotactic tripeptide and x-ray crystal structure of a 4-amino-1,2-dithiolane-4-carboxylic acid derivative 93
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 93
null 92
null 92
Protein kinase C mediates human neutrophil cytotoxicity 91
Differences arising in human neutrophil activation passing from N-formyl to N-acetyl-oligopeptides 90
Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe. 90
null 90
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 89
Pseudopeptides containing the 2-hydrazonoacyl fragment: Analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe 89
Probing structural requirements of fMLP receptor: on the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide. 89
N-Benzyl-2-chloroindole-3-carboxylic acids as potential anti-inflammatory agents. Synthesis and screening for the effects on human neutrophil functions and on COX1/COX2 activity 89
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 88
null 87
null 87
null 86
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'-(methylthio)ethyl]methionine residue. 86
Oligomeric formylpeptide activity on human neutrophils 85
Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms 83
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. 81
null 80
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 79
b-peptido sulfonamides. For-Met-Leu-Phe-OMe analogues containing taurine and chiral b-amino-ethansulfonic acid residues 78
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 78
Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16 74
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 74
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 73
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 72
Attivita' tumoricida dei neutrofili 72
An exhaustive insight into the pocket charge features of the methionine receptor using fMLP analogs. 71
Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety 70
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 69
HLA B51 antigen associated with neutrophil hyper-reactivity 68
NEW CHEMOTACTIC PEPTIDE ANALOGS WITH HIGH BIOLOGICAL ACTIVITY FOR HUMAN NEUTROPHILS 67
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 66
Valutazione funzionale dei leucociti. 65
An exhaustive insight into the pocket cherge features of the methionine receptor using fMLP analogs. 64
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 64
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 64
Solution structure of the amino acid sequence coded by the rarely expressed exon 26A of human elastin: the N-terminal region. 63
2-phenyl-1-arylcarbamoyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 63
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 62
Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing ß-alanine or taurine at the central position 62
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 61
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 61
Effects of Synthetic Peptides on the Inflammatory Response and Their Therapeutic Potential. 59
Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. J.Pept.Sci, 18, 418-426, 2012. 58
Synthesis, conformational and biological activity of centrally modified pseudopeptidic analogues of for-Met-Leu-Phe-OMe. 58
null 57
Tetrapeptide derivates as full and partial agonists of human neutrophil formylpeptide receptors. 57
Peptide T revised: conformational mimicry of epitopes of anti-HIV proteins. 57
alfa-Peptide/beta-sulfonamidopeptide hybrids: analogues of the chemotactic agent For-Met-Leu-Phe-OMe; 57
Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains. 54
Met-Ile-Phe-Leu derivates: full and partial agonist towards formyl peptide receptors of human neutrophils. 54
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 54
Totale 9.132
Categoria #
all - tutte 38.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 441
Totale 38.507


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.327 410 81 75 335 142 250 191 233 166 272 129 43
2020/20211.451 133 228 66 155 33 147 54 165 22 160 196 92
2021/20221.290 40 162 102 89 61 35 54 64 37 83 144 419
2022/20231.270 132 61 52 153 224 199 62 112 170 7 53 45
2023/2024517 69 66 31 14 27 106 23 51 9 3 4 114
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 10.079